Samer Choucair: Vision 2030 Strengthens the Investment Appeal of Healthcare and Nutritional Supplements
Entrepreneur Samer Choucair said growing global interest in preventive healthcare, led by efforts to address vitamin D deficiency, is reshaping the investment landscape across the healthcare sector.
He noted that this shift extends beyond rising demand for nutritional supplements to create strategic opportunities in early diagnosis, digital health, pharmaceuticals, and medical products, strengthening the sector’s appeal to institutional investors and sovereign wealth funds.
Samer Choucair explained that the nutritional-supplement and preventive-healthcare market is experiencing structural growth driven by increasing awareness of micronutrient deficiencies, particularly vitamin D deficiency.
This is changing consumer spending patterns and directing capital toward companies capable of providing long-term preventive solutions supported by innovation and technology.
He added that rising global healthcare costs, demographic change, and increasing life expectancy are encouraging investors to seek companies that combine early diagnosis with prevention.
Such business models offer stronger potential for sustainable growth and long-term returns than conventional approaches.
Choucair noted that the global shift toward preventive health is taking place amid rising rates of chronic conditions associated with nutrient deficiencies.
Vitamin D is receiving increasing attention because of its role in supporting bone health, the immune system, and energy levels, contributing to stronger demand for nutritional supplements, diagnostic testing, and functional-health products.
He explained that advanced markets have witnessed rapid expansion in nutritional supplements, with compound annual growth rates exceeding those of traditional healthcare spending.
Demand is also accelerating in emerging markets, including Gulf Cooperation Council countries, because of changing lifestyles and increasing dependence on urban environments that limit natural exposure to sunlight.
“Institutional investors are closely monitoring companies that combine innovation in product formulations with access to digital distribution channels,” Samer Choucair said. “This model offers stronger profit margins and greater potential for regional expansion than traditional approaches.”
Preventive healthcare emerges as a defensive investment sector
Choucair emphasized that growth in nutritional supplements is directly connected to global economic conditions.
As central banks continue managing inflation and interest rates, investors are seeking defensive sectors with relatively stable demand.
Preventive healthcare has become one of the most prominent of these sectors because consumers generally continue spending on health even during periods of slower economic growth.
Samer Choucair added that shares in pharmaceutical and nutritional-supplement companies have recently experienced volatility linked to higher raw-material prices and manufacturing costs.
However, the long-term outlook remains supported by structural factors including ageing populations, stronger health awareness, and increasing government healthcare expenditure across several markets, particularly in the Gulf.
He explained that sovereign wealth funds and asset managers are assigning greater priority to investments combining financial returns with positive health outcomes as chronic diseases place increasing pressure on public budgets.
This strengthens the importance of companies operating in prevention and early diagnosis.
Saudi Vision 2030 creates a favourable investment environment
Samer Choucair noted that Saudi Arabia provides a leading example of this transformation through the objectives of Vision 2030, which emphasize improved quality of life, stronger preventive healthcare, support for sporting activity, better nutrition, and lower long-term healthcare burdens.
He added that these initiatives create a favourable environment for local and international companies operating in nutritional supplements and medical testing.
They also support increased investment in domestic pharmaceutical manufacturing, supply-chain development, and digital-health platforms.
Choucair emphasized that the interest of the Public Investment Fund and other major investment institutions in healthcare reflects the sector’s importance as a principal pillar of economic diversification.
Investment in domestic manufacturing and regional supply chains strengthens health security and increases self-sufficiency in medical supplies and nutritional supplements.
“Companies capable of localizing production or building strategic partnerships with public healthcare institutions will enjoy a sustainable competitive advantage,” Samer Choucair said. “This is particularly important as Saudi Arabia seeks to strengthen health security and self-sufficiency.”
Three priorities for institutional capital
Choucair explained that institutional capital is currently concentrating on three principal areas within the sector.
These include companies with advanced research-and-development capabilities for producing innovative vitamin D formulations and related supplements, digital platforms combining home testing with personalized health recommendations, and regional companies benefiting from rising demand across Gulf and Middle Eastern markets.
Samer Choucair added that private-equity and venture-capital markets are showing growing interest in start-ups operating in functional health.
Meanwhile, the valuations of listed companies increasingly reflect expectations of earnings growth driven by market-share expansion rather than price increases alone.
He warned that tighter regulation of health-related product claims requires investors to focus more closely on governance and compliance.
These factors have become among the most important criteria for evaluating healthcare investment opportunities.
Choucair noted that volatility in raw-material and energy prices may affect profit margins over the short term, although growing structural demand provides strong support for future expansion.
Competition, regulation, and artificial intelligence
Samer Choucair explained that the competitive environment faces several challenges, including increasing pressure from global brands, regulatory change, and the possibility that some consumers may favour comprehensive dietary programmes over individual supplements.
However, he emphasized that integrating artificial intelligence into personalized diagnosis and health recommendations creates new growth opportunities.
He added that investment opportunities also extend to logistics and supply chains supporting the distribution of health products, as well as expansion into high-population-growth markets across Africa and Asia.
Strategic outlook
Concluding his remarks, Samer Choucair emphasized that preventive healthcare and nutritional supplements will continue attracting capital flows during the coming years, supported by long-term economic and demographic factors.
Alignment with the objectives of Saudi Vision 2030 gives the sector additional momentum across the Gulf region.
Choucair concluded that a successful investment strategy in this field depends on selecting companies with competitive advantages in innovation, distribution, and governance, while continuously monitoring regulatory developments and changes in consumer behaviour.
He explained that carefully constructed positions in preventive healthcare within diversified portfolios can provide institutional investors with a partial hedge against volatility in traditional markets while offering exposure to the structural long-term growth of healthcare expenditure.